Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Journal of Medical Research
Published in: European Journal of Medical Research 1/2023

Open Access 01-12-2023 | Multiple Sclerosis | Review

Speech deficits in multiple sclerosis: a narrative review of the existing literature

Authors: Panagiotis Plotas, Vasiliki Nanousi, Anastasios Kantanis, Eirini Tsiamaki, Angelos Papadopoulos, Angeliki Tsapara, Aggeliki Glyka, Efraimia Mani, Fay Roumelioti, Georgia Strataki, Georgia Fragkou, Konstantina Mavreli, Natalia Ziouli, Nikolaos Trimmis

Published in: European Journal of Medical Research | Issue 1/2023

Login to get access

Abstract

Multiple sclerosis (MS) is a chronic inflammatory and demyelinating autoimmune disease. MS patients deal with motor and sensory impairments, visual disabilities, cognitive disorders, and speech and language deficits. The study aimed to record, enhance, update, and delve into our present comprehension of speech deficits observed in patients with MS and the methodology (assessment tools) studies followed. The method used was a search of the literature through the databases for May 2015 until June 2022. The reviewed studies offer insight into speech impairments most exhibited by MS patients. Patients with MS face numerous communication changes concerning the phonation system (changes observed concerning speech rate, long pause duration) and lower volume. Moreover, the articulation system was affected by the lack of muscle synchronization and inaccurate pronunciations, mainly of vowels. Finally, there are changes regarding prosody (MS patients exhibited monotonous speech). Findings indicated that MS patients experience communication changes across various domains. Based on the reviewed studies, we concluded that the speech system of MS patients is impaired to some extent, and the patients face many changes that impact their conversational ability and the production of slower and inaccurate speech. These changes can affect MS patients’ quality of life.
Literature
1.
2.
3.
Goldenberg MM. Disease overview multiple sclerosis review. Vol. 37, P&T®. 2012.
4.
Lassmann H. Multiple sclerosis pathology, Cold Spring Harbor Perspectives in Medicine, vol. 8, New York: Cold Spring Harbor Laboratory Press; 2018.
5.
Bagert B, Camplair P, Bourdette D. Cognitive dysfunction in multiple sclerosis natural history. Pathophysiol Manage CNS Drugs. 2002;16(7):445–55.CrossRef
6.
Mey GM, Mahajan KR, DeSilva TM. Neurodegeneration in multiple sclerosis, Vol. 15, WIREs Mechanisms of Disease. John Wiley and Sons Inc, 2023.
7.
Pouly S, Antel JP. Multiple sclerosis and central nervous system demyelination. J Autoimmun [Internet]. 1999;13(3):297–306.PubMedCrossRef
8.
Bientinesi R, Coluzzi S, Gavi F, Nociti V, Gandi C, Marino F, et al. The impact of neurogenic lower urinary tract symptoms and erectile dysfunctions on marital relationship in men with multiple sclerosis: a single cohort study. J Clin Med. 2022;11(19):5639.PubMedPubMedCentralCrossRef
9.
10.
Rejdak K, Jackson S, Giovannoni G. Multiple sclerosis: a practical overview for clinicians. Br Med Bull. 2010;95:79–104.PubMedCrossRef
11.
Calabresi PA. Diagnosis and management of multiple sclerosis. Am Fam Physician. 2004;70(10):1935–44.PubMed
12.
Pugliatti M, Rosati G, Carton H, Riise T, Drulovic J, Vécsei L, et al. The epidemiology of multiple sclerosis in Europe. Eur J Neurol. 2006;13:700–22.PubMedCrossRef
13.
14.
Lublin FD, Reingold SC, Cohen JA, Cutter GR, Soelberg Sørensen P, Alan Thompson DJ, et al. VIEWS & REVIEWS Defining the clinical course of multiple sclerosis the 2013 revisions. 2014.
15.
Wynia K, Middel B, van Dijk JP, De Keyser JHA, Reijneveld SA. The impact of disabilities on quality of life in people with multiple sclerosis. Mult Scler. 2008;14(7):972–80.PubMedCrossRef
16.
Rosti-Otajärvi E, Hämäläinen P. Behavioural symptoms and impairments in multiple sclerosis: a systematic review and meta-analysis. Mult Scler J. 2013;19:31–45.CrossRef
17.
Fisher PL, Salmon P, Heffer-Rahn P, Huntley C, Reilly J, Cherry MG. Predictors of emotional distress in people with multiple sclerosis: a systematic review of prospective studies. J Affect Disord. 2020;276:752–64.PubMedCrossRef
18.
Zakzanis KK. Distinct neurocognitive profiles in multiple sclerosis subtypes. Arch Clin Neuropsychol. 2000;15(2):115–36.PubMedCrossRef
19.
MacKenzie C, Green J. Cognitive-linguistic deficit and speech intelligibility in chronic progressive multiple sclerosis. Int J Lang Commun Disord. 2009;44(4):401–20.PubMedCrossRef
20.
21.
22.
23.
24.
25.
26.
El-Wahsh S, Balandin S, Bogaardt H, Kumfor F, Ballard KJ. Managing communication changes in persons with multiple sclerosis: findings from qualitative focus groups. Int J Lang Commun Disord. 2022;57(3):680–94.PubMedPubMedCentralCrossRef
27.
28.
Benedict RHB, Cookfair D, Gavett R, Gunther M, Munschauer F, Garg N, et al. Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc. 2006;12(4):549–58.PubMedCrossRef
29.
Langdon DW, Amato MP, Boringa J, Brochet B, Foley F, Fredrikson S, et al. Recommendations for a brief international cognitive assessment for multiple sclerosis (BICAMS). Mult Scler J. 2012;18(6):891–8.CrossRef
30.
Portaccio E, Stromillo ML, Goretti B, Zipoli V, Siracusa G, Battaglini M, et al. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis. Neurology. 2009;73(7):498–503.PubMedCrossRef
31.
De Dios PB, Cordova Luna E, Cloutman L, Rog D, Preston E, Conroy P. Anomia in people with rapidly evolving severe relapsing-remitting multiple sclerosis: both word retrieval inaccuracy and delay are common symptoms. Aphasiology. 2020;34(2):195–213.CrossRef
32.
Friend KB, Grattan L. Use of the North American adult reading test to estimate premorbid intellectual function in patients with multiple sclerosis. J Clin Exp Neuropsychol. 1998;20(6):846–51.PubMedCrossRef
33.
Nelson HE, Willison JR. The revised national adult reading test–test manual, vol. 991. Windsor: NFER-Nelson; 1991. p. 1–6.
34.
Nelson HE, Willison J. National adult reading test (NART). Windsor: Nfer-Nelson; 1991.
35.
36.
Howard D, Patterson KE. The pyramids and palm trees test. 1992
37.
Lago S, Bevilacqua F, Stabile MR, Scarpazza C, Bambini V, Arcara G. Case report: pragmatic impairment in multiple sclerosis after worsening of clinical symptoms. Front Psychol. 2022;13:1028814.PubMedPubMedCentralCrossRef
38.
Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444.PubMedCrossRef
39.
Alonso RN, Eizaguirre MB, Silva B, Pita MC, Yastremiz C, Vanotti S, et al. Brain function assessment of patients with multiple sclerosis in the expanded disability status scale a proposal for modification. Int J MS Care. 2020;22(1):31–5.PubMedPubMedCentralCrossRef
40.
Ntoskou K, Messinis L, Nasios G, Martzoukou M, Makris G, Panagiotopoulos E, et al. Cognitive and language deficits in multiple sclerosis: comparison of relapsing remitting and secondary progressive subtypes. Open Neurol J. 2018;12(1):19–30.PubMedPubMedCentralCrossRef
41.
42.
El-Wahsh S, Bogaardt H, Kumfor F, Ballard K. Development and validation of the communication and language assessment questionnaire for persons with multiple sclerosis (CLAMS). Mult Scler Relat Disord. 2020;43: 102206.PubMedCrossRef
43.
Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR. The Addenbrooke’s Cognitive Examination revised (ACE-R): A brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry. 2006;21(11):1078–85.PubMedCrossRef
44.
Connick P. Impairment of visual cognition in progressive multiple sclerosis. J Mult Scler (Foster City). 2014;1:129.
45.
46.
Yorkston KM, Beukelman DR, Traynor C. Assessment of intelligibility of dysarthric speech. Pro-ed Austin, TX; 1984.
47.
Mackenzie C, Green J. Cognitive–linguistic deficit and speech intelligibility in chronic progressive multiple sclerosis. Int J Lang Commun Disord. 2009;44(4):401–20.PubMedCrossRef
48.
Morawska J, Niebudek-Bogusz E, Stasiołek M, Świderek-Matysiak M, Pietruszewska W. Speech pathology-specific questionnaire for persons with multiple sclerosis (SMS): adaptation, validation and preliminary assessment of the diagnostic potential. Mult Scler Relat Disord. 2021;1:49.
49.
El-Wahsh S, Heard R, Bogaardt H. Development and validation of a speech pathology-specific questionnaire for persons with multiple sclerosis (SMS). Int J Speech Lang Pathol. 2019;21(6):553–63.PubMedCrossRef
50.
51.
Bauer V, Aleric Z, Jancic E. Comparing voice self-assessment with auditory perceptual analysis in patients with multiple sclerosis. Int Arch Otorhinolaryngol. 2015;19(2):100–5.PubMed
52.
Bauer V, Aleric Z, Jancic E, Knezevic B, Prpic D, Kacavenda A. Subjective and perceptual analysis of voice quality and relationship with neurological disfunction in multiple sclerosis patients. Clin Neurol Neurosurg. 2013;115:S17-20.PubMedCrossRef
53.
De Bodt MS, Wuyts FL, Van de Heyning PH, Croux C. Test-retest study of the GRBAS scale: Influence of experience and professional background on perceptual rating of voice quality. J Voice. 1997;11(1):74–80.PubMedCrossRef
54.
Jacobson BH, Johnson A, Grywalski C, Silbergleit A, Jacobson G, Benninger MS, et al. The voice handicap index (VHI) development and validation. Am J Speech Lang Pathol. 1997;6(3):66–70.CrossRef
55.
Noffs G, Boonstra FMC, Perera T, Butzkueven H, Kolbe SC, Maldonado F, et al. Speech metrics, general disability, brain imaging and quality of life in multiple sclerosis. Eur J Neurol. 2021;28(1):259–68.PubMedCrossRef
56.
Vogel AP, Fletcher J, Maruff P. The impact of task automaticity on speech in noise. Speech Commun. 2014;65:1–8.CrossRef
57.
Sapir S, Ramig LO, Spielman JL, Fox C. Formant centralization ratio: A proposal for a new acoustic measure of dysarthric speech. J Speech Lang Hear Res. 2010;53(1):114–25.PubMedCrossRef
58.
Kent RD, Weismer G, Kent JF, Vorperian HK, Duffy JR. Acoustic studies of dysarthric speech: Methods, progress, and potential. J Commun Disord. 1999;32(3):141–86.PubMedCrossRef
59.
Holtbernd F, Deppe M, Bachmann R, Mohammadi S, Ringelstein EB, Reilmann R. Deficits in tongue motor control are linked to microstructural brain damage in multiple sclerosis: a pilot study. BMC Neurol. 2015;15(1).
60.
61.
Noffs G, Boonstra FMC, Perera T, Kolbe SC, Stankovich J, Butzkueven H, et al. Acoustic speech analytics are predictive of cerebellar dysfunction in multiple sclerosis. Cerebellum. 2020;19(5):691–700.PubMedCrossRef
62.
Fazeli M, Moradi N, Soltani M, Naderifar E, Majdinasab N, Latifi SM, et al. Dysphonia characteristics and vowel impairment in relation to neurological status in patients with multiple sclerosis. J Voice. 2020;34(3):364–70.PubMedCrossRef
63.
Rusz J, Benova B, Ruzickova H, Novotny M, Tykalova T, Hlavnicka J, et al. Characteristics of motor speech phenotypes in multiple sclerosis. Mult Scler Relat Disord. 2018;1(19):62–9.CrossRef
64.
Mantero V, Abate L, Balgera R, La Mantia L, Salmaggi A. Clinical application of 2017 McDonald diagnostic criteria for multiple sclerosis. J Clin Neurol (Korea). 2018;14(3):387–92.CrossRef
65.
Cutter GR, Baier ML, Rudick RA, Cookfair DL, Fischer JS, Petkau J, et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain. 1999;122(5):871–82.PubMedCrossRef
66.
Mefferd AS, Lai A, Bagnato F. A first investigation of tongue, lip, and jaw movements in persons with dysarthria due to multiple sclerosis. Mult Scler Relat Disord. 2019;1(27):188–94.CrossRef
67.
Nordio S, Bernitsas E, Meneghello F, Palmer K, Stabile MR, Dipietro L, et al. Expiratory and phonation times as measures of disease severity in patients with Multiple Sclerosis. A case-control study. Mult Scler Relat Disord. 2018;23:27–32.PubMedCrossRef
68.
69.
Rusz J, Vaneckova M, Benova B, Tykalova T, Novotny M, Ruzickova H, et al. Brain volumetric correlates of dysarthria in multiple sclerosis. Brain Lang. 2019;1(194):58–64.CrossRef
70.
Feenaughty L, Guo LY, Weinstock-Guttman B, Ray M, Benedict RHB, Tjaden K. Impact of cognitive impairment and dysarthria on spoken language in multiple sclerosis. J Int Neuropsychol Soc. 2021;27(5):450–60.PubMedCrossRef
71.
Metadata
Title
Speech deficits in multiple sclerosis: a narrative review of the existing literature
Authors
Panagiotis Plotas
Vasiliki Nanousi
Anastasios Kantanis
Eirini Tsiamaki
Angelos Papadopoulos
Angeliki Tsapara
Aggeliki Glyka
Efraimia Mani
Fay Roumelioti
Georgia Strataki
Georgia Fragkou
Konstantina Mavreli
Natalia Ziouli
Nikolaos Trimmis
Publication date
01-12-2023
Publisher
BioMed Central
Published in
European Journal of Medical Research / Issue 1/2023
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-023-01230-3

Other articles of this Issue 1/2023

European Journal of Medical Research 1/2023 Go to the issue

Research

Association between the Triglyceride–Glucose Index and Non-Alcoholic Fatty Liver Disease in patients with Atrial Fibrillation

Research

RNA-seq research landscape in Africa: systematic review reveals disparities and opportunities

Research

A predictive model for the risk of sepsis within 30 days of admission in patients with traumatic brain injury in the intensive care unit: a retrospective analysis based on MIMIC-IV database

Research

Complement C3 mediates podocyte injury through TLR4/NFΚB-P65 signaling during ischemia–reperfusion acute kidney injury and post-injury fibrosis

Research

A prediction model for permanent pacemaker implantation after transcatheter aortic valve replacement

Research

Low m6A modification-mediated upregulation of PLAC8 promotes trophoblast cell invasion and migration in preeclampsia